Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Genvor (GNVR) Research & Development (2021 - 2026)

Genvor has reported Research & Development over the past 2 years, most recently at -$212048.0 for Q3 2022.

  • For Q3 2022, Research & Development changed N/A year-over-year to -$212048.0; the TTM value through Dec 2022 reached -$109248.0, changed N/A, while the annual FY2025 figure was $455901.0, 89.75% up from the prior year.
  • Research & Development for Q3 2022 was -$212048.0 at Genvor, down from $102800.0 in the prior quarter.
  • Over five years, Research & Development peaked at $102800.0 in Q1 2022 and troughed at -$212048.0 in Q3 2022.